Daiichi Sankyo has committed Y100m ($1m) and Mitsubishi UFJ Capital will be investing as much as Y200m ($2m) with the Organization for Small & Medium Enterprises and Regional Innovation pledging Y450m ($4.5m).
Japan-based pharmaceutical company Daiichi Sankyo and Japan corporate investment unit Mitsubishi UFJ Capital have launched an open innovation business through the Organization for Small & Medium Enterprises and Regional Innovation (OiDE Fund Investment Limited Partnership). The fund will be operated by Mitsubishi UFJ Capital with combined commitments of Y750m ($7.5m). Daiichi Sankyo has committed Y100m…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
